Datascope settles InterVascular SA (France) litigation:
This article was originally published in Clinica
Datascope has accepted a cash payment of $12 million to settle litigation brought by its wholly-owned subsidiaries InterVascular and InterVascular SA (France) against several former employees and other defendants. The agreement settles all claims between the parties and releases both sides from any liability arising from the litigation.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.